Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
華爾街上最準確的分析師評估了3家擁有3%以上股息收益率的醫療保健股票
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
在市場動盪和不確定的時期，許多投資者會轉向股息收益股，這些通常是具有較高的自由現金流並以高紅利派息獎勵股東的公司。
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy.
Benzinga讀者可以訪問分析師股票評級頁面，查看他們最喜歡的股票的最新分析師觀點。交易員可以篩選Benzinga廣泛的分析師評級數據庫，包括按分析師準確度篩選。
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
以下是醫療保健板塊三隻高收益股票最準確的分析師評級。
Patterson Companies, Inc. (NASDAQ:PDCO)
Patterson Companies, Inc. (納斯達克:PDCO)
- Dividend Yield: 4.93%
- Baird analyst Jeff Johnson maintained a Neutral rating and cut the price target from $30 to $28 on Aug. 29. This analyst has an accuracy rate of 78%.
- Evercore ISI Group analyst Ross Muken maintained an In-Line rating and lowered the price target from $25 to $23 on Aug. 29. This analyst has an accuracy rate of 65%.
- Recent News: On Aug. 28, Patterson Companies reported worse-than-expected first-quarter adjusted EPS and sales.
- Benzinga Pro's real-time newsfeed alerted to latest PDCO news.
- 股息收益率: 4.93%
- Baird分析師Jeff Johnson仍維持中立評級，並將價格目標從$30降至$28，日期爲8月29日。該分析師準確率爲78%。
- Evercore ISI Group分析師Ross Muken仍維持持平評級，並將價格目標從$25降至$23，日期爲8月29日。該分析師準確率爲65%。
- 最新資訊: 8月28日，Patterson Companies報告了低於預期的第一季度調整後每股收益和銷售額。
- Benzinga Pro的實時新聞提醒了最新的PDCO新聞。
Johnson & Johnson (NYSE:JNJ)
強生公司（紐交所股票代碼：JNJ）
- Dividend Yield: 3.01%
- Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $215 on Sept. 3. This analyst has an accuracy rate of 72%.
- Morgan Stanley analyst Terence Flynn maintained an Equal-Weight rating and raised the price target from $167 to $169 on July 18. This analyst has an accuracy rate of 72%.
- Recent News: Johnson & Johnson will host a conference call on Tuesday, Oct. 15th to review third-quarter results.
- Benzinga Pro's charting tool helped identify the trend in JNJ stock.
- 股息率：3.01%
- 康泰納分析師Louise Chen於9月3日重申對股票的買入評級，目標價爲215美元。該分析師的準確率爲72%。
- 摩根士丹利分析師Terence Flynn於7月18日維持持有評級，將目標價從167美元上調至169美元。該分析師的準確率爲72%。
- 最新資訊：強生公司將於10月15日星期二舉行電話會議，審查第三季度業績。
- Benzinga Pro的圖表工具幫助確認了JNJ股票的趨勢。
CVS Health Corporation (NYSE:CVS)
西維斯健康公司（紐約證券交易所股票代碼：CVS）
- Dividend Yield: 4.58%
- RBC Capital analyst Ben Hendrix reiterated an Outperform rating with a price target of $68 on Sept. 4. This analyst has an accuracy rate of 76%.
- Barclays analyst Andrew Mok maintained an Equal-Weight rating and cut the price target from $65 to $63 on Aug. 8. This analyst has an accuracy rate of 74%.
- Recent News: On Aug. 14, CVS Health named Heidi Capozzi Executive Vice President, Chief People Officer.
- Benzinga Pro's signals feature notified of a potential breakout in CVS shares.
- 股息率：4.58%
- RBC Capital分析師本·亨德里克斯在9月4日重申了對68美元的買入評級。該分析師的準確率爲76%。
- 巴克萊銀行分析師安德魯·莫克在8月8日維持了均衡評級，並將價格目標從65美元下調至63美元。該分析師的準確率爲74%。
- 最新資訊：西維斯健康於8月14日任命Heidi Capozzi爲執行副總裁兼首席人力官。
- Benzinga Pro的信號特徵指出CVS股票的潛在突破。
Read More:
更多閱讀：
- Jim Cramer: Oklo Is Losing Money 'Hand-Over-Fist,' But This Private Equity Stock Is A Buy
- Jim Cramer表示：Oklo正在大量虧損，但這家股權投資公司是一個買入的股票
資訊熱榜
更新時間